This shows the total count of Earnings Estimate Upgrades (for FY2) by brokers/analysts in the last month. It should be contrasted with EPS Downgrades.
While broker recommendations in and of themselves do not appear to have much (any?) signal given the inherent positive bias in them, changes in a) forecasts and, to a lesser extent, recommendation have been shown by academic research to be much more meaningful.
| Ticker | Name | # 1m Upgrades | StockRank™ |
|---|---|---|---|
| NSQ:MSFT | Microsoft | 16 | 92 |
| NSQ:BIIB | Biogen Inc | 15 | 98 |
| NSI:INFY | Infosys | 15 | 92 |
| NYQ:INFY | Infosys | 15 | 87 |
| NYQ:NVS | Novartis AG | 12 | 92 |
Let’s get you setup so you get the most out of our service
Brilliant - You've created a folio! Now let's add some stocks to it.
